Format

Send to

Choose Destination
Am J Public Health. 2011 Oct;101(10):1850-7. doi: 10.2105/AJPH.2011.300205. Epub 2011 Aug 18.

Another look at the human papillomavirus vaccine experience in Canada.

Author information

1
Department of Health Policy, Management and Evaluation at the University of Toronto, Toronto, Ontario, Canada. catherine.mah@utoronto.ca

Abstract

Policy debates about immunization frequently focus on classic trade-offs between individual versus collective well-being. Publicly funded immunization programs are usually justified on the basis of widespread public benefit with minimal individual risk. We discuss the example of the policy process surrounding the adoption of the human papillomavirus (HPV) vaccine in Canada to consider whether public good arguments continue to dominate immunization policymaking. Specifically, we show how a range of stakeholders framed HPV vaccination as a personal-rather than a public-matter, despite the absence of a controversy over mandatory immunization as was the case in the United States. Our findings suggest an erosion of the persuasiveness of public good arguments around collective immunization programs in the policy discourse.

PMID:
21852642
PMCID:
PMC3222351
DOI:
10.2105/AJPH.2011.300205
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center